Skip to main content

Table 2 No. of subjects with cancer by diabetes status, Incidence Rate Ratios (IRR) and 95% Confidence Intervals (95%CI) for subjects with diabetes vs subjects without diabetes

From: Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy

Cancer sitea Total Females Males
No DM DM IRR 95% CI No DM DM IRR 95% CI No DM DM IRR 95% CI
All sites 9858 1464 1.22 1.15–1.29 4851 563 1.25 1.15–1.37 5007 901 1.17 1.05–1.39
C16: Stomach 396 58 0.95 0.72–1.26 139 20 1.17 0.72–1.88 257 38 0.87 0.66–2.21
C18-C20: Colon-rectum 956 177 1.32 1.12–1.55 455 59 1.12 0.85–1.49 501 118 1.44 1.25–2.60
C22: Liver 207 99 3.37 2.63–4.32 61 23 3.26 2.00–5.35 146 76 3.40 2.40–7.16
C24: Biliary tract 69 16 1.41 0.81–2.45 28 7 1.76 0.76–4.04 41 9 1.22 0.07–4.58
C25: Pancreas 340 101 2.00 1.60–2.51 155 48 2.49 1.79–3.46 185 53 1.68 0.65–2.61
C33-C34: Lung 1047 177 1.10 0.93–1.29 329 36 1.01 0.71–1.43 718 141 1.11 0.67–1.47
C50: Breast 1643 148 1.05 0.89–1.26 1633 147 1.06 0.89–1.26 10 1 - -
C54: Corpus uteri - - - - 249 44 1.84 1.33–2.56 - - - -
C56: Ovary - - - - 139 21 1.56 0.97–2.49 - - - -
C61: Prostate - - - - - - - - 938 134 0.86 0.72–1.04
C64-C66; C68: Kidney 377 60 1.20 0.67–2.14 111 19 1.55 0.94–2.54 266 41 1.02 0.74–1.44
C67;D09: Bladder 627 138 1.39 1.16–1.68 126 25 1.72 1.11–2.66 501 113 1.33 1.08–1.64
C73: Thyroid 504 27 1.00 0.67–1.49 368 18 1.05 0.64–1.70 136 9 0.88 0.44–1.77
C82-C85; C96: NHLb 425 56 1.09 0.82–1.44 180 20 1.14 0.71–1.82 245 36 1.05 0.74–1.50
Other sitesc 2252 277 1.09 0.96–1.23 1001 102 1.11 0.89–1.36 1251 175 1.07 0.91–1.25
  1. aOnly first primary cancers are listed. Non-melanoma skin cancer (C44), chronic myeloproliferative disorders and myelodysplastic syndromes (D45-D47) were not counted as a cancer diagnosis; bNon-Hodgkin lymphoma; cCancers not in any mentioned group. IRR = calculated using Poisson model, adjusted for age, foreign status, and sex (when no stratified). People without diabetes were used as reference